Hong Zhao

FDA Approval Summary: Dabrafenib in Combination with Trametinib for <i>BRAF</i>V600E Mutation–Positive Low-Grade Glioma

Michael I. Barbato, Jeannette Nashed, Diana Bradford et al. · Clinical Cancer Research · 2023 · 71 citations · Full text

Medicine, Oncology, Pharmacology +14

FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma

Timil H. Patel, Jamie R. Brewer, Jiaxin Fan et al. · Clinical Cancer Research · 2023 · 63 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

FDA Approval Summary: Amivantamab for the Treatment of Patients with Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations

Katie Chon, Erin Larkins, Somak Chatterjee et al. · Clinical Cancer Research · 2023 · 56 citations · Full text

Medicine, Oncology, Pharmacology +15

FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum

Sonia Singh, Diana Bradford, Xiaoxue Li et al. · Clinical Cancer Research · 2023 · 44 citations · Full text

Medicine, Pediatrics, Radiology +13

FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma

Michael H. Brave, William F. Maguire, Chana Weinstock et al. · Clinical Cancer Research · 2024 · 30 citations · Full text

Medicine, Oncology, Pharmacotherapy +13